Navigating the Challenges of Commercializing a New Drug-Device Combination Product

Oct 08, 2024

Posted by Stevanato Group

Developing a drug-device combination product is a complex process since each device reacts differently to the drug product. Expert support is crucial prior to Engineering Verification and Design Verification to optimize your product and avoid costly changes.

This is why our Technology Excellence Centers (TECs) offer tailored guidance and testing services throughout product development and clinical phases, helping you minimize risks and speed up time to market.

In this video you wil discover more from the words of our Product Manager for Analytical Services download our latest e-book published on Drug Development and Delivery: https://www.stevanatogroup.com/en/offering/analytical-services/testing-on-drug-delivery-systems/

 

Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients.

 

See all Member News